These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8232699)

  • 1. Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases.
    de Man RA; Metselaar HJ; Heijtink RA; Schalm SW
    Neth J Med; 1993 Aug; 43(1-2):74-82. PubMed ID: 8232699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis B after liver transplantation.
    Krüger M
    Clin Transplant; 2000; 14 Suppl 2():14-9. PubMed ID: 10965959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liver transplantation in patients with hepatitis B infection.
    Holt CD; Millis JM; Busuttil RW
    Clin Transplant; 1995 Jun; 9(3 Pt 2):269-76. PubMed ID: 7670175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses].
    Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
    Z Gastroenterol; 1992 Sep; 30(9):576-82. PubMed ID: 1449005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B and D recurrence after liver transplantation].
    Grendele M; Colledan M; Doglia M; Fassati LR; Ferla G; Gridelli B; Maggi U; Reggiani P; Rossi G; Caccamo L
    Minerva Med; 1991 Apr; 82(4):151-61. PubMed ID: 2017310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
    Iacob S; Hrehoret D; Matei E; Dorobantu B; Gangone E; Gheorghe L; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):383-8. PubMed ID: 19104697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver transplantation for chronic hepatitis B].
    Samuel D
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt 2):S25-33. PubMed ID: 18662607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: hepatitis B and liver transplantation.
    Mutimer D
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1031-41. PubMed ID: 16611263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and management of hepatitis B virus reinfection after liver transplantation].
    Ma Y; Tai Q; He XS; Wang GD; Hu AB
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1209-12. PubMed ID: 19781163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
    Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
    Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent liver transplantation survival and prevention of hepatitis B recurrence using hepatitis B immunoglobulin and nucleoside or nucleotide analogue along with treating physician adherence to treatment protocol.
    Lindenger C; Castedal M; Cahlin C; Friman S
    Transplant Proc; 2013 Apr; 45(3):1188-92. PubMed ID: 23622656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft.
    Rakela J; Wooten RS; Batts KP; Perkins JD; Taswell HF; Krom RA
    Mayo Clin Proc; 1989 Apr; 64(4):429-32. PubMed ID: 2654499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.